Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 10/20 | 0.59 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 3/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.43 |
| ▸ | CES1 | P23141 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3854141 | 0.98 | EPHX2 (0.62) | EPHX2FAAHKMT2AALDH1A1TSHR | |
| SCHEMBL5678990 | 0.98 | EPHX2 (0.62) | EPHX2FAAHKMT2AALDH1A1TSHR | |
| SCHEMBL1075076 | 0.85 | ALDH1A1 (0.49) | EPHX2KMT2AALDH1A1TSHRLMNA | |
| Bromide SCHEMBL11776660 | 0.82 | EPHX2 (0.47) | EPHX2KMT2AALDH1A1TSHR | |
| SCHEMBL28292841 | 0.82 | KMT2A (0.49) | EPHX2FAAHKMT2AALDH1A1TSHR | |
| SCHEMBL5678988 | 0.81 | EPHX2 (0.44) | EPHX2ALDH1A1TSHRLMNAHSD11B1 | |
| SCHEMBL5675125 | 0.81 | EPHX2 (0.44) | EPHX2ALDH1A1TSHRLMNAHSD11B1 | |
| Heptanoate SCHEMBL6270549 | 0.80 | GPR84 (0.57) | EPHX2KMT2AALDH1A1TSHR | |
| Bromide SCHEMBL11772739 | 0.79 | EPHX2 (0.47) | EPHX2KMT2AALDH1A1TSHR | |
| Bromide SCHEMBL11778924 | 0.79 | EPHX2 (0.47) | EPHX2KMT2AALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250312504-A1 | VOLATILE COMPOSITION DISPENSER FOR COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | THE PROCTER & GAMBLE COMPANY | 2025-10-09 | — | — | US | disclosed |
| US-20240336868-A1 | COMPOSITIONS COMPRISING ADAMANTYL ESTER-CONTAINING COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2024-10-10 | — | — | US | disclosed |
| US-20240199997-A1 | COMPOSITIONS COMPRISING A META-(C1-C4 ALKOXY) SALICYLALDEHYDE | PROCTER & GAMBLE COMPANY, THE | 2024-06-20 | — | — | US | disclosed |
| US-7208551-B2 | Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same | UNIVERSITY OF DAYTON (US) | 2007-04-24 | — | — | US | disclosed |
| US-20050043449-A1 | Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same | UNIVERSITY OF DAYTON | 2005-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050043449-A1 | Polyaryleneetherketone phosphine oxide compositions incorporating cycloaliphatic units for use as polymeric binders in thermal control coatings and method for synthesizing same | PNKP, PHOSPHO1, KTN1 | EPHX2 3251/4885FAAH 2496/4885KMT2A 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.